BioSpace News Archive

Business

Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an overview of recent and upcoming business highlights.

March 5, 2024
·
12 min read
Genetown

Morphic to Participate in March 2024 Investor Conferences

Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, announced its participation at investor conferences during the month of March.

March 5, 2024
·
1 min read
Er-Kim Selected to Join the World Economic Forum’s New Champions Community

Er-Kim announced it has been selected to join the World Economic Forum’s New Champions Community, a group of dynamic forward-looking companies that are championing new business models, emerging technologies, and sustainable growth strategies.

March 5, 2024
·
2 min read
Biotech Beach

Phenomenex Introduces Biozen dSEC-7, A New Way to Study AAVs with Unprecedented Speed and Efficiency

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, proudly announces its newest Size Exclusion Chromatography product, Biozen dSEC-7, for the analysis of AAVs.

March 5, 2024
·
2 min read
Drug Development

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata

Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, today announced the initiation of its Phase 2b clinical trial evaluating rezpegaldesleukin in patients with severe to very severe alopecia areata.

March 5, 2024
·
7 min read
Drug Development

N-803 Combined with Natural Killer Cells Showed Potential to Reduce HIV Viral Load in HIV Positive Subjects; Part of HIV Cure Study

ImmunityBio (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced data from a Phase 1 pilot study showed N-803 combined with natural killer cells could have the potential to reduce viral load in people living with HIV.

March 5, 2024
·
7 min read
Deals

Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business

Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc.

March 5, 2024
·
2 min read
Business

Transformative Gift from Salesforce Chair and CEO Marc Benioff and Lynne Benioff Will Expand Access and Continuity of Healthcare in Hawai’i

A major donation by longstanding philanthropists in Hawai’i will significantly increase healthcare access, addressing critical infrastructure gaps and helping ensure excellent and continuous care for communities in Hawai’i.

March 5, 2024
·
8 min read
BioMidwest

Lehigh Valley Health Network selects Medline for new prime vendor partnership agreement

Medline announced it has entered into a multi-year prime vendor distribution agreement with Lehigh Valley Health Network, one of the nation’s leading health networks, offering comprehensive care in 95 clinical specialties across 13 hospital campuses in service of patients across eastern Pennsylvania.

March 5, 2024
·
2 min read
Biotech Beach

Nalu Medical, Inc. Closes $85 Million Series E Round

Nalu Medical, Inc. announced the closing of an incremental $20M in equity financing from new investor B Capital, bringing the total Series E round of equity investment to $85M.

March 5, 2024
·
4 min read